Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiko Sekine

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vaccine: X|November 21, 2022
COVID-19 site readiness initiative: Building clinical trial capacity for vaccine efficacy trials in Latin America in response to the pandemicSue Ann Costa Clemens, Ana Keiko Sekine, Fernanda Tovar-Moll, et al.
Biochemical and Biophysical Research Communications|March 23, 2005
HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cellsKeiko Sekine, Yanyan Hao, Yasuyuki Suzuki, et al.
Biological & Pharmaceutical Bulletin|April 6, 2006
A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cellsYurika Saitoh, Keiichi Koizumi, Takayuki Minami, et al.
Bioorganic & Medicinal Chemistry|March 4, 2008
Degradation-promoters of cellular inhibitor of apoptosis protein 1 based on bestatin and actinoninShinichi Sato, Masashi Tetsuhashi, Keiko Sekine, et al.
The Journal of Biological Chemistry|January 31, 2008
Small molecules destabilize cIAP1 by activating auto-ubiquitylationKeiko Sekine, Kohei Takubo, Ryo Kikuchi, et al.
Cancer Letters|February 10, 2006
Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesisKazuteru Fukasawa, Hideji Fujii, Yurika Saitoh, et al.
International Journal of Cancer|June 19, 2013
Antimyeloma activity of NK012, a micelle-forming macromolecular prodrug of SN-38, in an orthotopic modelOsamu Miyazaki, Keiko Sekine, Naoko Nakajima, et al.
Nature Cell Biology|August 10, 2004
Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection functionYanyan Hao, Keiko Sekine, Atsushi Kawabata, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccine: X|November 21, 2022
COVID-19 site readiness initiative: Building clinical trial capacity for vaccine efficacy trials in Latin America in response to the pandemicSue Ann Costa Clemens, Ana Keiko Sekine, Fernanda Tovar-Moll, et al.
Biochemical and Biophysical Research Communications|March 23, 2005
HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cellsKeiko Sekine, Yanyan Hao, Yasuyuki Suzuki, et al.
Biological & Pharmaceutical Bulletin|April 6, 2006
A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cellsYurika Saitoh, Keiichi Koizumi, Takayuki Minami, et al.
Bioorganic & Medicinal Chemistry|March 4, 2008
Degradation-promoters of cellular inhibitor of apoptosis protein 1 based on bestatin and actinoninShinichi Sato, Masashi Tetsuhashi, Keiko Sekine, et al.
The Journal of Biological Chemistry|January 31, 2008
Small molecules destabilize cIAP1 by activating auto-ubiquitylationKeiko Sekine, Kohei Takubo, Ryo Kikuchi, et al.
Cancer Letters|February 10, 2006
Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesisKazuteru Fukasawa, Hideji Fujii, Yurika Saitoh, et al.
International Journal of Cancer|June 19, 2013
Antimyeloma activity of NK012, a micelle-forming macromolecular prodrug of SN-38, in an orthotopic modelOsamu Miyazaki, Keiko Sekine, Naoko Nakajima, et al.
Nature Cell Biology|August 10, 2004
Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection functionYanyan Hao, Keiko Sekine, Atsushi Kawabata, et al.
Pageof 1